A novel missense mutation in the human plasmin inhibitor (alpha2- antiplasmin) gene associated with a bleeding tendency

British Journal of Haematology

Volumn 107, Issue 2, 1999, Pages 317-322

  Lind, Bent ^a   Thorsen, Sixtus ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Alpha2 antiplasmin; Bleeding; Mutation; Plasmin inhibitor deficiency; Serine proteinase inhibitor

Indexed keywords

ALPHA 2 ANTIPLASMIN; DNA; POLYCLONAL ANTIBODY; SERINE PROTEINASE INHIBITOR;

ALLELE; ARTICLE; BLEEDING TENDENCY; BLOOD TRANSFUSION; CASE REPORT; FEMALE; GENE MUTATION; HEMOSTASIS; HUMAN; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

ADULT; AMINO ACID SUBSTITUTION; ANTIPLASMIN; BREAST DISEASES; FEMALE; HEMATOMA; HEMORRHAGIC DISORDERS; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 0032708630     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01708.x     Document Type: Article

References (29)

1. 2-plasmin inhibitor in human plasma. Biochemical Journal, 291, 623-625.
2. Berkenpas, M.B., Lawrence, D.A. & Ginsburg, D. (1995) Molecular evolution of plasminogen activator inhibitor-1 functional stabilily. EMBO Journal, 14, 2969-2977.
3. Carrell, R.W. & Stein, P.E. (1996) The biostructural pathology of the serpins: critical function of sheet opening mechanism. Biological Chemistry Hoppe-Seyler, 377, 1-17.
4. Chapman, H.A. (1997) Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Current Opinion in Cell Biology, 9, 714-724.
5. Eldering, E., Verpy, E., Roem, D., Meo, T. & Tosi, M. (1995) COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. Journal of Biological Chemistry, 270, 2579-2587.
6. Fay, W.P., Parker, A.C., Condrey, L.R. & Shapiro, A.D. (1997) Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Blood, 90, 204-208.
7. Gils, A. & Declerck, P.J. (1998) Structure-function relationships in serpins: current concepts and controversies. Thombosis and Haemostasis, 80, 531-541.
8. 2-plasmin inhibitor gene. Proceedings of the National Academy of Sciences of the United States of America, 85, 6836-6840.
9. 2-Antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science, 238, 209-211.
10. 2-antiplasmin, a serine proteinase inhibitor (serpin). Journal of Biological Chemistry, 262, 1659-1664.
11. 2-plasmin inhibitor. Journal of Biological Chemistry, 261, 15591-15595.
12. 2-antiplasmin in blood. Blood, 67, 616-622.
13. Lijnen, H.R. & Collen, D. (1989) Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis, 3, 67-77.
14. Lind, B., Van Solinge, W.W., Schwartz,. M. & Thorsen, S. (1993) Splice site mutation in the human protein C gene associated with venous thrombosis: demonstration of cxon skipping by ectopic transcript analysis. Blood, 82, 2423-2432.
15. Meijer, M. v. & Pannekoek, H. (1995) Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update. Fibrinolysis, 9, 263-276.
16. 2-antiplasmin production. Journal of Clinical Investigation, 97, 2478-2484.
17. 2-plasmin inhibitor. Blood, 75, 1092-1096.
18. 2-plasmin inhibitor: a frameshift mutation leading to elongation of the deduced amino acid sequence. Journal of Clinical Investigation, 83, 1598-1604.
19. 137 by a trinucleotide deletion blocks intracellular transport. Journal of Biological Chemistry, 264, 18213-18219.
20. Müllertz, S. & Clemmensen, I. (1976) The primary inhibitor of plasmin in human plasma. Biochemical Journal, 159, 545-553.
21. Philips, M., Juul, A.-G., Selmer, J., Lind, B. & Thorsen, S. (1992) A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma-standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease. Thombosis and Haemostasis, 68, 486-494.
22. 1,-Antitrypsin deficiency associated liver disease. Journal of Gastroenterology and Hepatology, 12, 404-416.
23. Rijken, D.C., Groeneveld, E., Kluft, C. & Nieuwenhuis, H.K. (1988) Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin. Biochemical Journal, 255, 609-615.
24. 2-antiplasmin. Journal of Biological Chemistry, 262, 6055-6059.
25. Stein, P.E. & Carrell, R.W. (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nature Structural Biology, 2, 96-113.
26. 2-plasmin inhibitor to plasminogen. Biochimica et Biophysica Acta, 952, 1-7.
27. 2-plasmin inhibitor deduced from the cDNA sequence. Journal of Biochemistry (Tokyo), 102, 1033-1041.
28. Weeke, B. (1973) Crossed immunoelectrophoresis. A Manual of Quantitative Immunoelectrophoresis: Methods and Applications (ed. by N. H. Axelsen, J. Krøll and B. Weeke), pp. 47-56. Blackwell Scientific Publications, Oxford.
29. Wiman, B. & Hamsten, A. (1990) The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease. Seminars in Thrombosis and Hemostasis, 16, 207-216.